Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.
Kronox Lab Sciences IPO
Price Band
₹129.0–136.0
Issue Size
₹130.15 Cr
Lot Size
110 shares
Min Investment
₹14,960
GMP
+₹28.0 (20.59%)
Issue Price
₹136.0
Subject to Sauda
₹2300
Paid only if allotted
Kronox Lab Sciences IPO AI Summary
- Kronox Lab Sciences IPO is listed on BSE, NSE in the Specialty Chemicals sector.
- Price band: ₹129.0–₹136.0 per share, lot size 110 shares (min. investment ₹14,960).
- Subscription window: 03 Jun–05 Jun 2024, listing on 10 Jun 2024.
- Current GMP is +₹28.0 (20.59%), an estimated listing price of ₹164 — unofficial and can change daily.
TopFund is not SEBI-registered — this is educational analysis, not personalized investment advice.
Kronox Lab Sciences IPO — Third-Party Research Views
Reviews below reflect analyst calls made before this IPO closed on 05 Jun 2024 — not a current signal.
5 of 9 reviewers say Neutral
Recommendations are sourced from third-party research firms and are not TopFund's own investment advice.
Important Dates
Subscription Status
Subscription data unavailable
Kronox Lab Sciences IPO Grey Market Premium (GMP) Today
GMP
+₹28.0
GMP %
+20.59%
Est. Listing
₹164.0
Updated: 25 Jul 2026 14:05
About the Company
Incorporated in 2008, Kronox Lab Sciences Limited is a manufacturer of high-purity speciality fine chemicals for diverse end-user industries. The company's High Purity Specialty Fine Chemicals are used in various applications such as manufacturing APIs, pharmaceutical formulations, scientific research, nutraceuticals, biotech applications, agrochemical formulations, personal care products, metal refineries, and animal health products. The company offers a wide range of over 185 products, including phosphate, sulphate, acetate, chloride, citrate, nitrates, nitrites, carbonate, EDTA derivatives, hydroxide, succinate, gluconate, and others. These products are supplied to customers in India and more than 20 countries worldwide. The company exports its products to countries such as United States, Argentina, Mexico, Australia, Egypt, Spain, Turkey, United Kingdom, Belgium, United Arab Emirates, China, among others. The company has three manufacturing facilities in Vadodara, Gujarat, close to the seaports of Mundra, Kandla, Hazira, and Nhava Sheva. The facilities cover 17,454 sq. m. and have an installed capacity of 7,242 TPA as of December 31, 2023. Unit I/II holds FSSC 22000 (Version 5), ISO 9001:2015, ISO 14001:2015, and ISO 45001:2018 certifications. Additionally, some products manufactured at Unit I have obtained Kosher, Halal, GMP, and GLP certifications. As of December 31, 2023, the company is conducting research and development on 122 products. The company has served over 592 customers in the past three years. By December 31, 2023, 141 customers of the total, placed repeat orders. As of December 31, 2023, the company employees 212 people at various levels.
Company Financials (₹ Cr)
As of 2023-12-31
| Period Ended | 31 Dec 2023 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
|---|---|---|---|---|
| Assets | 66.96 | 54.03 | 56.79 | 37.65 |
| Total Income | 68.44 | 97.50 | 83.34 | 63.24 |
| Profit After Tax | 15.47 | 16.62 | 13.63 | 9.73 |
| NET Worth | 60.28 | 44.68 | 40.35 | 26.81 |
| Reserves and Surplus | 15.56 | 7.58 | 40.11 | 26.57 |
| Total Borrowing | 0.64 | 0.01 |
Key Ratios
EPS
₹4.48
NAV
₹16.25
ROE
25.66%
ROCE
33.15%
RoNW
25.66%
P/B Value
8.37
P/E Ratio
30.37
Market Cap
₹504.61 Cr
PAT Margin
22.60%
Peer Comparison
| Company | NAV | RoNW | P/E (x) | EPS Basic | EPS Diluted |
|---|---|---|---|---|---|
| DMCC Speciality Chemical Limited | 79.49 | 3.5% | 116.57 | 2.78 | 2.78 |
| Sigachi Industries Limited | 8.73 | 16.22% | 46.64 | 1.42 | 1.42 |
| Neogen Chemicals Ltd | 182.9 | 10.36% | 77.55 | 18.94 | 18.94 |
| Tanfac Industries Ltd. | 184.74 | 30.46% | 39.15 | 56.27 | 56.27 |
| Tatva Chintan Pharma Chem Limited | 220.07 | 8.84% | 57.57 | 19.45 | 19.45 |
| Kronox Lab Sciences Limited This IPO | 12.04 | 37.19% | — | 4.3 | 4.3 |
Promoters
Jogindersingh Jaswal, Ketan Ramani and Pritesh Ramani
Objects of the Issue
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects: # Issue Objects Est Amt (₹ Cr.) 1 Achieve the benefits of listing the Equity Shares on the Stock Exchanges
IPO Evaluation
Generated 23 Sep 2026Revenue Trend
Total income was ₹63.24 Cr in the period ending 31 Mar 2021, rising to ₹83.34 Cr by 31 Mar 2022, but then decreased to ₹97.50 Cr by 31 Mar 2023. In the most recent period ending 31 Dec 2023, total income was ₹68.44 Cr, though this is a 9-month figure, not a full year, so isn't directly comparable.
Profit Trend
Profit after tax was ₹9.73 Cr in the period ending 31 Mar 2021, increasing to ₹13.63 Cr by 31 Mar 2022, and further rising to ₹16.62 Cr by 31 Mar 2023. In the latest period ending 31 Dec 2023, profit after tax was ₹15.47 Cr, though this is a 9-month figure, not a full year, so isn't directly comparable.
Valuation
Kronox Lab Sciences Limited has an implied P/E ratio of approximately 30.37 at the issue price of ₹136.0, compared to peers trading at P/E ratios ranging from 39.15 to 116.57.
Grey Market Premium, Explained
The Grey Market Premium (GMP) is an indicator of the expected listing price of an IPO. It reflects the demand and supply dynamics of the shares before they are officially listed on the stock exchange. A positive GMP indicates that the shares are likely to list at a premium compared to the issue price.
Who This IPO Suits
Investors comfortable with short-term volatility and a long-term horizon typically weigh IPOs like this against their overall investment strategy, considering factors such as market conditions and the company's growth potential.
Who May Want to Wait
Investors who prefer stable and established companies with predictable earnings might want to avoid IPOs like this, which can be subject to market fluctuations and uncertainties.
Listing Gains — The Risk
Listing-day gains can be unpredictable and may not reflect the long-term performance of the stock. Factors such as market sentiment, overall economic conditions, and company performance can influence the stock price on the day of listing.
This evaluation is generated from Kronox Lab Sciences's own public IPO filing data for educational purposes and is not investment advice or a recommendation to apply, subscribe to, or avoid this issue — see Broker Recommendations below for named third-party research views (clearly attributed, not TopFund's own). TopFund is not a SEBI-registered investment adviser — see our Disclaimer.
Frequently Asked Questions
What is Kronox Lab Sciences IPO GMP today?
Kronox Lab Sciences IPO GMP today is +₹28.0 (20.59%), indicating an estimated listing price of ₹164. GMP is an unofficial grey-market indicator and can change daily.
What is the price band of Kronox Lab Sciences IPO?
The price band of Kronox Lab Sciences IPO is ₹129.0–₹136.0 per share.
When does Kronox Lab Sciences IPO open and close?
Kronox Lab Sciences IPO opens on 03 June 2024 and closes on 05 June 2024.
When does Kronox Lab Sciences IPO list on the stock exchange?
Kronox Lab Sciences IPO listed on 10 June 2024 at ₹164.0.
What is the lot size for Kronox Lab Sciences IPO?
The lot size for Kronox Lab Sciences IPO is 110 shares, requiring a minimum investment of ₹14,960.
What is the price band for the IPO?
The price band for the IPO is ₹129.0 to ₹136.0.
What is the minimum investment required?
The minimum investment required is ₹14,960.0.
What is the lot size for this IPO?
The lot size for this IPO is 110 shares.
When is the listing date?
The listing date is scheduled for June 10, 2024.
What does GMP stand for?
GMP stands for Grey Market Premium, which indicates the expected premium at which the shares may list on the stock exchange.
Issue Details
Investor Allocation
Registrar
Lead Managers / Book Running
IPO Timeline
Open
03 Jun 2024
Close
05 Jun 2024
Allotment
06 Jun 2024
Listing
10 Jun 2024
Similar IPOs in Specialty Chemicals
Plan Your IPO Investment
Related Articles
Community Sentiment
What are other investors planning for Kronox Lab Sciences?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
No comments yet — start the discussion.